son of T/FIF Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : son of T/FIF

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (310)	12/29/1999 2:57:00 PM
From: scaram(o)uche	of 673

>> I know that the cry is "off label". They need to get a label first. Then they need to find an indication where the off-label use makes sense in light of side effects. << first step in-hand...... this is about as good as the news could have been.... refractory, all stages..... indicates that Regulatory is getting the job done..... good for LGND, good for biotech..... still, another small market..... biz.yahoo.com Wednesday December 29, 2:24 pm Eastern Time Company Press Release FDA Approves Ligand's Targretin Capsules for Early and Advanced-Stage Refractory CTCL

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next